Latip, Abdul Amin A.
HRN: 24-17-44 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/29/2023
12/06/2023
IV
95mg
Q24H
Sepsis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes